Detalhe da pesquisa
1.
Gilteritinib with or without venetoclax for relapsed/refractory FLT3-mutated acute myeloid leukaemia.
Br J Haematol
; 2024 May 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38782575
2.
Venetoclax-based salvage therapy for adult patients with relapsed/refractory acute lymphoblastic leukemia.
Eur J Haematol
; 111(3): 365-372, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37254665
3.
Evaluating outcomes of adult patients with acute lymphoblastic leukemia and lymphoblastic lymphoma treated on the GMALL 07/2003 protocol.
Ann Hematol
; 101(3): 581-593, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35088172
4.
Venetoclax in combination with FLAG-IDA-based protocol for patients with acute myeloid leukemia: a real-world analysis.
Ann Hematol
; 101(8): 1719-1726, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35732976
5.
Gilteritinib monotherapy for relapsed/refractory FLT3 mutated acute myeloid leukemia: a real-world, multi-center, matched analysis.
Ann Hematol
; 101(9): 2001-2010, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35739428
6.
Cardiac Disorders Associated with Cellular Therapy and Novel Agents for Acute Leukemia.
Isr Med Assoc J
; 24(3): 170-174, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35347930
7.
Midostaurin in combination with chemotherapy is most effective in patients with acute myeloid leukemia presenting with high FLT3-ITD allelic ratio who proceed to allogeneic stem cell transplantation while in first complete remission.
Eur J Haematol
; 106(1): 64-71, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-32949053
8.
Venetoclax combinations induce high response rates in newly diagnosed acute myeloid leukemia patients ineligible for intensive chemotherapy in routine practice.
Am J Hematol
; 96(7): 790-795, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33836555
9.
Willingness and concerns of transfusion-dependent hematological patients toward the option of home transfusion therapy.
Palliat Med
; 35(5): 927-932, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33761783
10.
Sequential therapy for patients with primary refractory acute myeloid leukemia: a historical prospective analysis of the German and Israeli experience.
Haematologica
; 104(9): 1798-1803, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30733263
11.
Midostaurin in combination with intensive chemotherapy is safe and associated with improved remission rates and higher transplantation rates in first remission-a multi-center historical control study.
Ann Hematol
; 98(12): 2711-2717, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31512015
12.
Correction to: Gilteritinib monotherapy for relapsed/refractory FLT3 mutated acute myeloid leukemia: a realworld, multicenter, matched analysis.
Ann Hematol
; 101(9): 2011, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35869985
13.
The management of hodgkin lymphomas in pregnancies.
Eur J Haematol
; 99(5): 385-391, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28850718
14.
Recent Advances in the Biology and CD123-Directed Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm.
Clin Lymphoma Myeloma Leuk
; 24(4): e130-e137, 2024 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38267355
15.
Regulation of the action of early mitotic inhibitor 1 on the anaphase-promoting complex/cyclosome by cyclin-dependent kinases.
J Biol Chem
; 286(19): 16647-57, 2011 May 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-21454540
16.
Venetoclax is safe and efficacious in relapsed/refractory AML.
Leuk Lymphoma
; 61(9): 2221-2225, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32420775
17.
Inhibitory factors associated with anaphase-promoting complex/cylosome in mitotic checkpoint.
Proc Natl Acad Sci U S A
; 104(12): 4870-5, 2007 Mar 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-17360335
18.
Roles of the anaphase-promoting complex/cyclosome and of its activator Cdc20 in functional substrate binding.
Proc Natl Acad Sci U S A
; 103(7): 2081-6, 2006 Feb 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-16455800
19.
Role of Polo-like kinase in the degradation of early mitotic inhibitor 1, a regulator of the anaphase promoting complex/cyclosome.
Proc Natl Acad Sci U S A
; 101(21): 7937-42, 2004 May 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-15148369